From: Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction
irAE | Grades 1/2 (N, %) | Grades 3/4 (N, %) |
---|---|---|
Arthralgias | 1 (4 %) | 0 |
Colitis | 0 | 1 (4 %) |
Conjunctivis | 1 (4 %) | 0 |
Diarrhea | 1 (4 %) | 0 |
Hepatitis | 0 | 2 (7 %) |
Hypothyroidism | 4 (15 %) | 0 |
Nephritis | 2 (7 %) | 0 |
Pruritis | 1 (4 %) | 0 |
Rash | 3 (11 %) | 0 |
Vitiligo | 1 (4 %) | 0 |